Daiichi Sankyo Co Ltd

Common Name
Daiichi Sankyo
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
19,765
Ticker
4568
Exchange
TOKYO STOCK EXCHANGE
Description
Daiichi Sankyo Co., Ltd. is a prominent pharmaceutical company based in Japan, specializing in the research, development, and manufacturing of pharmaceutical products. The company's primary focus is o...

Daiichi Sankyo's Financial Statements Preview

Below are the financial statements of Daiichi Sankyo, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in trillions of JPY
2023
2022
2021
2020
2019
2018
Revenue
1.6a
1.28a
1.04a
0.96a
0.98a
0.93a
Operating profit
0.21a
0.12a
0.07a
0.06a
0.14a
0.08a
Profit attributable to owners of the company
0.2a
0.11a
0.07a
0.08a
0.13a
0.09a
Research and development expenses
-0.37a
-0.34a
-0.26a
-0.23a
-0.2a
-0.2a
Depreciation and amortization
-0.06a
-0.07a
-0.06a
-0.06a
-0.05a
-0.05a
Download Data

Verified Sources Behind Daiichi Sankyo’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Daiichi Sankyo’s data sources below and access millions more through our Disclosure Search.

a. Daiichi Sankyo's Integrated Report 2024
a. Daiichi Sankyo's Integrated Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?